Send the following on WhatsApp
Continue to Chat(MELTEMI study )A Multicenter, Open-label,Safety Extension Study with Benralizumab (MEDI-563) for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting B2 Agonist - https://avesis.ankara.edu.tr/proje/2fd75cd2-a1ec-432b-8a0c-d98857ec679c/meltemi-study-a-multicenter-open-label-safety-extension-study-with-benralizumab-medi-563-for-asthmatic-adults-on-inhaled-corticosteroid-plus-long-acting-b2-agonist